Why the study?
Local recurrence remains the major challenge in retroperitoneal liposarcoma management, prompting the need for new combined treatment options to reduce recurrence and improve overall survival.
Preoperative radiotherapy followed by surgery is a feasible and well-tolerated approach for the management of giant primary retroperitoneal liposarcoma.
May suggest new combined therapy for retroperitoneal liposarcoma; hypothesis-generating and requires prospective validation before practice change.
Despite the development of contemporary surgical management of retroperitoneal liposarcomas, local recurrence remains the major challenge in the treatment of these tumors. Currently, surgery is the main treatment option for liposarcoma. The international cancer community faces a global goal — the development of new combined treatment options for the treatment of retroperitoneal liposarcoma to reduce the postoperative recurrence rate and increase the overall survival. This article presents the world literature data on the treatment of retroperitoneal liposarcomas and demonstrates a case report describing treatment of a patient with this disease in the N. N. Blokhin NMRC of Oncology.
No takes yet. Share an insight, caveat, or question.
Bart et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: